Cambridge Financial Group, LLC Abb Vie Inc. Transaction History
Cambridge Financial Group, LLC
- $311 Billion
- Q3 2025
A detailed history of Cambridge Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cambridge Financial Group, LLC holds 2,503 shares of ABBV stock, worth $570,759. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,503
Previous 2,503
-0.0%
Holding current value
$570,759
Previous $465 Million
24.74%
% of portfolio
0.19%
Previous 0.17%
Shares
6 transactions
Others Institutions Holding ABBV
# of Institutions
4,356Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.2 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.51 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $403B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...